FDA committee rejects two IQOS MRTP claims, approves one
25th January 2018 - News analysis |
Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction
Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction
Philip Morris International (PMI) has submitted its iQOS heat-not-burn system for approval by the U.S. Food and Drug Administration (FDA).
Philip Morris International (PMI) is testing its iQOS heat-not-burn product in Russia, ECigIntelligence has confirmed.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.